Cancer Cures News ArticlesExcerpts of Key Cancer Cures News Articles in Media
There are no magic bullets in the fight against cancer: that's the first thing every responsible scientist mentions when discussing a possible new treatment, no matter how promising. If there were a magic bullet, though, it might be something like dichloroacetate, or DCA, a drug that kills cancer cells by exploiting a fundamental weakness found in a wide range of solid tumors. So far, though, it kills them just in test tubes and in rats infected with human cancer cells; it has never been tested against cancer in living human beings. DCA ... is an existing drug whose side effects are well-studied and relatively tolerable. Also, it's a small molecule that might be able to cross the blood-brain barrier to reach otherwise intractable brain tumors. Within days after a technical paper on DCA appeared in the journal Cancer Cell last week, the lead author, Dr. Evangelos Michelakis of the University of Alberta, was deluged with calls and e-mails from prospective patients—to whom he can say only, “Hang in there.” DCA is a remarkably simple molecule. It acts in the body to promote the activity of the mitochondria. Researchers have assumed that the mitochondria in cancer cells were irreparably damaged. But Michelakis wondered if that was really true. With his colleagues he used DCA to turn back on the mitochondria in cancer cells—which promptly died. One of the great things about DCA is that it's a simple compound, in the public domain, and could be produced for pennies a dose. But that's also a problem, because big drug companies are unlikely to spend a billion dollars or so on large-scale clinical trials for a compound they can't patent.
Note: For a 2010 follow-up by Dr. Michelakis with promising results, click here and watch a 10-minute video at this link. For the DCA website, click here. Thank you Newsweek for this important article. Why haven't any other mass media reported this major story? Why aren't many millions of dollars being poured into research? Notice even Newsweek acknowledges the drug companies are not interested in finding a cure for cancer if they can't make a profit from it. Some suspect the drug companies have even suppressed cancer cures found in the past. For one amazing example of this, click here.
We could make faster progress against cancer by changing the way drugs are developed. In the current system, if a promising compound can’t be patented, it is highly unlikely ever to make it to market — no matter how well it performs in the laboratory. The development of new cancer drugs is crippled as a result. The reason for this problem is that bringing a new drug to market is extremely expensive. In 2001, the estimated cost was $802 million; today it is approximately $1 billion. To ensure a healthy return on such staggering investments, drug companies seek to formulate new drugs in a way that guarantees watertight patents. In the meantime, cancer patients miss out on treatments that may be highly effective and less expensive to boot. In 2004, Johns Hopkins researchers discovered that an off-the-shelf compound called 3-bromopyruvate could arrest the growth of liver cancer in rats. The results were dramatic; moreover, the investigators estimated that the cost to treat patients would be around 70 cents per day. Yet, three years later, no major drug company has shown interest in developing this drug. The hormone melatonin, sold as an inexpensive food supplement in the United States, has repeatedly been shown to slow the growth of various cancers when used in conjunction with conventional treatments. Early this year, another readily available industrial chemical, dichloroacetate, was found by researchers at the University of Alberta to shrink tumors in laboratory animals by up to 75 percent. However ... dichloroacetate is not patentable, and the lead researcher is concerned that it may be difficult to find funding from private investors to test the chemical. Potential anticancer drugs should be judged on their scientific merit, not on their patentability.
Note: To explore several cancer cures which have shown dramatic potential, yet are not being studied for lack of funds due to inability to patent the process, click here. Why are these very promising treatments not being fast-tracked as the expensive AIDS drugs were? For a top MD's revealing comments on this, click here. And for why the media won't feature these promising cancer treatments in headlines, click here.
Researchers say they have created a drug that has killed every kind of cancer tumor it has come in contact with, according to Science Magazine. The antibody treatment works by blocking a protein called CD47 which tricks the body into not destroying cancerous cells. After the protein is blocked, the body can then recognize the cancer cells as invaders and attack. While the research is seen as a step closer to discovering a treatment that can cure all cancers, the drug has only been tested on mice and will need to prove itself on humans before it can be available to patients. This may take a few years. The research team has been given the green light and recently received a four-year, $20 million grant to conduct human clinical trials. Research for this new drug started a decade ago when biologist Irving Weissman at Stanford University was studying leukemia cells. He found that that leukemia cells produce higher levels of the CD47 protein than healthy cells. CD47 acts as a "don't-eat-me" signal, instructing the body to not eat harmful cells. Cancers take advantage of this signal to trick the immune system into ignoring them. Weissman's research showed that blocking CD47 can cure more than just blood cancers. The drug can also shrink or cure human breast, ovary, colon, bladder, brain, liver and prostate tumors that have been transplanted into mice. The treatment forced the mice's immune system to kill the cancer cells. This means this single drug could cure a variety of cancers and prevent cancers from spreading in the body.
Note: With many millions around the world dying of cancer every year, why aren't the most promising treatments being fast-tracked? Why is this article titled a "rumor"? Why isn't this making major headlines? Why isn't the very promising treatment of DCA, which is both cheap and incredibly promising, being given many millions to move rapidly forward? To read major media articles describing other potential cures not being adequately funded, click here. To understand why some treatments are suppressed, click here.
Last winter, inventor John Kanzius was already attempting one seemingly impossible feat -- building a machine to cure cancer with radio waves -- when his device inadvertently succeeded in another: He made saltwater catch fire. TV footage of his bizarre discovery has been burning up the blogosphere ever since, drawing crackpots and Ph.D.s alike into a raging debate. Can water burn? And if so, what good can come of it? Some people gush over the invention's potential for desalinization or cheap energy. Briny seawater, after all, sloshes over most of the planet's surface, and harnessing its heat energy could power all sorts of things. Skeptics say Kanzius's radio generator is sucking up far more energy than it's creating, making it a carnival trick at best. For now, Kanzius is tuning out the hubbub. Diagnosed with leukemia in 2002, he began building his radio-wave blaster the next year, soon after a relapse. If he could seed a person's cancerous cells with nanoscopic metal particles and blast them with radio waves, perhaps he could kill off the cancer while sparing healthy tissue. The saltwater phenomenon happened by accident when an assistant was bombarding a saline-filled test tube with radio waves and bumped the tube, causing a small flash. Curious, Kanzius struck a match. "The water lit like a propane flame," he recalls. "People said, 'It's a crock. Look for hidden electrodes in the water,' " says Penn State University materials scientist Rustum Roy, who visited [Kanzius] in his lab in August after seeing the feat on Google Video. A demo made Roy a believer. "This is discovery science in the best tradition," he says. Meanwhile, researchers at MD Anderson Cancer Center in Houston and the University of Pittsburgh Medical Center have made progress using Kanzius's technology to fight cancer in animals. They published their findings last month in the journal Cancer.
Note: For other compelling articles on this fascinating invention, see recent articles in the Los Angeles Times, ABC News, and especially Medical News Today. And for dozens of astounding major media articles showing clear suppression of potential cancer cures, click here.
In a new study, researchers found that breast-cancer patients who had high levels of vitamin D were twice as likely to survive [as] women with low levels. They reviewed five studies that observed more than 4,440 women. “The study has implications for including vitamin D as an adjuvant to conventional breast cancer therapy,” study co-author Dr. Heather Hofflich, an associate professor of medicine at the University of California San Diego, said in a press release. The researchers recommend that vitamin D should be added to the various treatments given to women fighting breast cancer. The body naturally produces vitamin D when exposed to sunlight, but milk, fatty fish and other foods can also boost production. Patients could also take vitamin D supplements.
Note: This is huge news! Why isn't this exciting development getting more press coverage? Read numerous major media articles revealing potential cancer cures which have received little attention. And see an excellent article with more on the Vitamin D connection.
Sixteen-year-old Jack Andraka's innovative mind led him to create a new way to detect pancreatic, ovarian and lung cancer. "I created a new way to detect pancreatic, ovarian and lung cancer that costs three cents and takes five minutes to run," he said. After a close friend died from pancreatic cancer, this 16-year-old from Crownsville, Maryland, unleashed his hyper-drive intellect on preventing more cancer deaths. "It's 168 times faster, over 26,000 times less expensive, and over 400 times more sensitive than our current methods of diagnosis," he said. Tinkering in his room and using information readily available online, he came up with a new way to detect cancer. "85 percent of all pancreatic cancers are diagnosed late, when someone has less than a two percent chance of survival. And our current test costs $800 per test and misses 30 percent of all pancreatic cancers," he said. He won last year's Intel International Science and Engineering Fair. The sweet validation came with $100,000 in scholarships, but Jack Andraka's got his eye on even bigger things. "The name of the competition is called the Tricorder XPRIZE," he said. "It's a $10 million prize. Essentially what you have to do is develop something the size of a smartphone that you scan over your skin and it will diagnose any disease instantly." Jack is fielding a team of other high-schoolers to compete against 300 teams of adult scientists and corporations in the Qualcomm Tricorder XPRIZE competition. He says youth is an advantage -- that new eyes are more likely to solve old problems.
Note: Let's hope this invention gets fast tracked and makes it to market. Notice how little attention this exciting development received. To read about many potential cancer cures reported in major media which have not made it to market for financial reasons, click here. For a treasure trove of great news articles which will inspire you to make a difference, click here.
Eric Merola's "Burzynski" charts how a Texas medical doctor and biochemist developed Antineoplastons, genetic-targeted medicines, and with them began to treat a wide range of cancers, including difficult-to-treat brain malignancies, with remarkable and continuing success only to bring down the full force of the medical establishment, which has laid assault to him in the most stupefying, devious and costly manner. Stanislaw Burzynski, a Polish immigrant ... eventually won a 14-year struggle – during which he found himself threatened with life imprisonment and astronomical fines for fraud and other violations – to obtain FDA-approved clinical trials of his Antineoplastons, an ordeal that cost Burzynski $2.2 million in legal expenses and the FDA $60 million in taxpayers' money. The film makes the case that big pharmacy holds the FDA in its thrall. Burzynski's Antineoplastons, with their high success rate and lack of side effects, pose a significant threat to the trillion-dollar industry of treating cancer with the traditional methods of surgery, radiation and chemotherapy.
Note: The Los Angeles Times now requires payment to view this article at this link. For the Burzynski clinic website, click here. You can watch part or all of this revealing movie at this link. For another powerful documentary featuring a variety of potential cancer cures that have been suppressed, click here. For excerpts from numerous major media articles with potential cancer cures that are being suppressed, click here.
In a major breakthrough in the search for a cure for cancer, the first human trials are to begin using a technique that has already been shown to destroy the disease in mice. The trials are the culmination of years of research prompted by the discovery of a cancer-proof mouse by researchers almost a decade ago. More than 20 cancer patients will be given white blood cells with cancer-killing properties in an attempt to boost their immune system's fight against the deadly illness. The work stems from experiments into the metabolism of a humble laboratory mouse whose immunity to cancer defied the repeated attempts of scientists to kill it with high-level doses of cancer cells. White blood cells taken from the animal and its offspring were subsequently used to cure other mice of advanced cancers. The white blood cells destroyed the cancer cells but left normal cells alone. This discovery encouraged scientists to study how people might be helped to fight off cancer by being given a boost of white blood cells called granulocytes. Laboratory tests have since shown how human granulocytes can destroy cervical, prostate and breast cancer cells, provided sufficient numbers of cancer-killing granulocytes from healthy donors are used. Scientists are now confident that the treatment will prove just as successful in humans as it has been in mice. Hundreds of donors will be recruited for the new treatment – which is called leukocyte infusion therapy – and a process similar to platelet donation will be used to collect the granulocytes.
White blood cells from mice that are naturally immune to cancer cured tumors in other mice and provided them with lifelong immunity to the disease, researchers reported Monday. The finding indicates the existence of a biological pathway previously unsuspected in any species. A small team of researchers is working to understand the genetic and immunological basis of the surprising phenomenon. Preliminary studies hint at the existence of a similar resistance in humans. Researchers hope that harnessing the biological process could lead to a new approach to treating cancer. But Dr. Zhen Cui of Wake Forest, whose team published the findings in the Proceedings of the National Academy of Science, said he expected rapid replication of the results because the findings were so clear-cut and easily observed. "This is a truly remarkable phenomenon -- and it really needs confirmation from other institutions," he said. The team took white blood cells from the immune mice ... and injected them into mice already carrying a variety of tumors, some of which were extremely aggressive. In every case, the cancers were destroyed, even if the cells were injected at a point distant from the tumor. Healthy tissues were not affected. The mice that received the cells, furthermore, were protected from new tumors for the rest of their lives. The researchers have no idea how the immunity continues.
Note: Why was this not in the headlines and not given a title like "Cancer Cure Found for Mice"? Most major papers didn't even report the story, and an article in the New York Times was titled simply "A Strain of Mice Appears Able to Resist Cancer Cells." Could it be that the power brokers in the medical industry know that a cancer cure would cause huge financial losses for them? For what happened to an incredible scientist in the past who discovered a cancer cure for humans, click here.
Germs that cause cancer have been discovered and with a new high-frequency radio "ray." They have been killed in human patients who then recovered, according to assertions made yesterday at the California State Homeopathic Medical society’s convention. The new progress in combating malignant cancer is said to have been made possible by an ultra microscope that magnifies 31,000 times and by a ray that kills micro-organisms in humans. Both the microscope and the Ray were developed by Royal Raymond Rife of San Diego. Rife was to have announced his discoveries before the British Medical Society, but made the announcement locally because of the war. Dr. Arthur W. Yale of San Diego reported that with the aid of the Rife Ray he has succeeded in curing a number of cases of malignant cancer in which patients had been told they had only a limited time in which to live. The physician [said that] "for 17 years Mr. Rife experimented with vibratory waves of all frequencies, and he has now succeeded in finding a rate that will kill the different invading organisms of the body. Radio waves, which with their harmonics range from 10 meters to 20,000 meters, are projected through a tube filled with helium gas. I have witnessed the disappearance of every malignant growth when the patient has remained under treatment." Dr. Yale then reported case histories of patients treated. Mr. Rife alluded to the fact that the medical profession has not yet accepted his findings. “My work may not be accepted during my lifetime," he said, "but ... I know it ultimately will be recognized.
Note: As the above link requires payment, you can read the full text of this article free at this link. For an abundance of powerful, verifiable information on this amazing man and how his cancer cure was ruthlessly suppressed by the medical establishment, click here.
High-dose vitamin C can boost the cancer-killing effect of chemotherapy in the lab and mice, research suggests. Given by injection, it could potentially be a safe, effective and low-cost treatment for ovarian and other cancers. US scientists ... call for large-scale government clinical trials. Vitamin C has long been used as an alternative therapy for cancer. In the 1970s, chemist Linus Pauling reported that vitamin C given intravenously was effective in treating cancer. However, clinical trials of vitamin C given by mouth failed to replicate the effect, and research was abandoned. It is now known that the human body quickly excretes vitamin C when it is taken by mouth. However, scientists at the University of Kansas say that when given by injection vitamin C is absorbed into the body, and can kill cancer cells without harming normal ones. The researchers injected vitamin C into human ovarian cancer cells in the lab, into mice, and into patients with advanced ovarian cancer. They found ovarian cancer cells were sensitive to vitamin C treatment, but normal cells were unharmed. The treatment worked in tandem with standard chemotherapy drugs to slow tumour growth. "Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies," said lead researcher Qi Chen. "We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C."
Note: Read more about this amazing cancer research. For more along these lines, see concise summaries of deeply revealing news articles on promising cancer research that has been suppressed by the medical industry.
Doctors have known that low levels of vitamin D are linked to certain kinds of cancers as well as to diabetes and asthma, but new research also shows that the vitamin can kill human cancer cells. The results fall short of an immediate cancer cure, but they are encouraging, medical professionals say. JoEllen Welsh, a researcher with the State University of New York at Albany, has studied the effects of vitamin D for 25 years. Part of her research involves taking human breast cancer cells and treating them with a potent form of vitamin D. Within a few days, half the cancer cells shriveled up and died. Welsh said the vitamin has the same effect as a drug used for breast cancer treatment. "Vitamin D enters the cells and triggers the cell death process," she [said]. "It's similar to what we see when we treat cells with Tamoxifen," a drug used to treat breast cancer. The vitamin's effects were even more dramatic on breast cancer cells injected into mice. After several weeks of treatment, the cancer tumors in the mice shrank by an average of more than 50 percent. Some tumors disappeared. Similar results have been achieved on colon and prostate cancer tumors in mice.
In a study, researchers have found that long-term pot smokers were roughly 62 percent less likely to develop head and neck cancers than people who did not smoke pot. The new study featured 434 patients with head and neck cancers, which include tumors in the mouth, tongue, nose, sinuses, throat and lymph nodes in the neck, and 547 individuals without these cancers seen in the Greater Boston area from December 1999 to December 2003. After factoring out the impact of smoking, drinking, and other factors that might influence the results, smoking marijuana from once every two weeks to three times every two weeks, on average, was associated with about half the risk of head and neck cancer, compared with less frequent use. Those who took up pot smoking at an older age appeared to have less risk of these cancers than those who started it at a younger age. Compared to people who never smoked pot, those who began smoking marijuana between the ages of 15 and 19 years were 47 percent less likely to develop head and neck cancer, while users who began at age 20 or older had a 61 percent reduced risk, Kelsey and colleagues found. The authors note that chemicals in pot called cannabinoids have been shown to have potential antitumor effects. Other studies have linked marijuana use to a reduced risk of some cancers, such as cancer of the prostate, and now head and neck cancer. It's also been suggested that smoking pot may help stave off Alzheimer's disease and help combat weight loss associated with AIDS, and nausea and vomiting associated with chemotherapy in cancer patients.
Note: For a great nine-minute video presenting major media reports showing how marijuana is a very promising cancer treatment that is being suppressed, click here. For deeply revealing reports from reliable major media sources on health issues, click here.
In what a dying Rick Smalley called the most important application from his Nobel Prize-winning discovery [of fullerines], Houston researchers are using [carbon] nanotubes heated by radio waves to kill cancer cells. In a paper posted online by the journal Cancer, a team at the University of Texas M.D. Anderson Cancer Center and Rice University reported that the technique destroyed liver cancer tumors in rabbits and caused no side effects. It is thought to hold the same potential for many other cancers. "I don't want to overstate matters — I'm the biggest skeptic in the world — given the challenges still ahead of us," Dr. Steven Curley, an M.D. Anderson surgical oncologist and the paper's senior author, said Thursday. "But my hope is that this will be a very useful tool to safely and efficiently treat a lot of types of cancer." The therapy marries two disparate disciplines: the relatively ancient field of radio waves and nanotechnology, the cutting-edge science of the ultra-small. The rabbit study found the therapy worked only when the two were used together. It works not by poisoning but by creating a localized hyperthermia — or small fever — that destroys the cancer cells' membranes, protein and even DNA. The cells then die and are carried out of the body through normal kidney functions. In the experiment recounted in Cancer, the rabbits were injected with a solution of single-walled carbon nanotubes — hollow cylinders of pure carbon measuring about a billionth of a meter across — then exposed to two minutes of radio-frequency treatment. The result, researchers said, was the thermal destruction of 100 percent of the tumors. The idea was inspired by John Kanzius, an M.D. Anderson leukemia patient and retired Pennsylvania radio and television station owner. He developed a radio-frequency generator after undergoing chemotherapy and noting its effect on himself and other patients.
Note: For many hopeful new developments in the search for cancer cures, click here.
Government nutrition researcher [Dr. Mark Levine] has published new evidence that suggests vitamin C can work like chemotherapy - only better. But so far, he hasn't been able to interest cancer experts in conducting the kind of conclusive studies that, one way or the other, would advance treatment. "If vitamin C is useful in cancer treatment, that's wonderful. If it's not, or if it's harmful, that's fine, too," said Levine, a Harvard-educated physician at the National Institute of Diabetes and Digestive and Kidney Diseases. The distinction between oral and intravenous is crucial. The body automatically gets rid of extra C through urine. Levine's lab has shown that, at high concentrations, the vitamin is toxic to many types of cancer cells in lab dishes. But to get that much C into the body before it's eliminated, it must be put directly into the blood. Five out of nine types of cancer cells that were put in simulated body-cavity fluid died when concentrated ascorbate or peroxide was added to the dish. And the best part: This same lethal marinade had no effect on healthy cells. "Interest is definitely growing," said Kenneth Bock, physician and president of the American College for Advancement in Medicine, an alternative-medicine society that teaches ascorbate infusion protocols. The American Cancer Society and the American Association of Clinical Oncologists warn patients against high-dose C, as do leading cancer centers such as the University of Pennsylvania's and Memorial Sloan-Kettering.
The phrase “cancer screening saves lives” is ... familiar to most consumers of public service announcements. But that advice may be misleading. The ubiquitous adage ... fails to take into account deaths linked to factors related to the screening itself. For example, prostate cancer screening is known to return “numerous” false positives, writes Vinay Prasad, an assistant professor at Oregon Health and Science University, and contributes to over 1 million prostate biopsies a year. The procedure is “associated with serious harms, including admission to hospital and death.” What’s more, men diagnosed with prostate cancer are “more likely to have a heart attack or commit suicide in the year after diagnosis,” he writes. A similar case can be made for breast cancer screening. Fully 60 percent of women who get regular mammograms for 10 years have been handed a false positive result at some point. Being told you have breast cancer - even if it turns out that the test result was incorrect - has been associated with “psychosocial distress as great as a breast cancer diagnosis.” A massive study of 90,000 women over 25 years found that the regular screening did not change the women’s death rates. In fact, if anything, the screenings harmed some women: Out of every five cancers detected with the technology and treated, one was “not a threat to the woman’s health and did not need treatment such as chemotherapy, surgery or radiation,” all of which can cause serious side effects.
Note: Read more about routine over-diagnosis and unnecessary treatment of cancer in this New York Times article. And learn about the promising cancer research that has been largely suppressed by the medical-industrial complex. For more, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
A group of experts advising the nation’s premier cancer research institution has recommended changing the definition of cancer and eliminating the word from some common diagnoses as part of sweeping changes in the nation’s approach to cancer detection and treatment. The recommendations, from a working group of the National Cancer Institute, were published [in] The Journal of the American Medical Association. They say, for instance, that some premalignant conditions, like one that affects the breast called ductal carcinoma in situ, which many doctors agree is not cancer, should be renamed to exclude the word carcinoma so that patients are less frightened and less likely to seek what may be unneeded and potentially harmful treatments that can include the surgical removal of the breast. The group, which includes some of the top scientists in cancer research, also suggested that many lesions detected during breast, prostate, thyroid, lung and other cancer screenings should not be called cancer at all but should instead be reclassified as IDLE conditions, which stands for “indolent lesions of epithelial origin.” The impetus behind the call for change is a growing concern among doctors, scientists and patient advocates that hundreds of thousands of men and women are undergoing needless and sometimes disfiguring and harmful treatments for premalignant and cancerous lesions that are so slow growing they are unlikely to ever cause harm. Once doctors and patients are aware a lesion exists, they typically feel compelled to biopsy, treat and remove it, often at great physical and psychological pain and risk to the patient.
Note: Isn't it interesting that a diagnosis which might not even be accurate can so change a person's life? For more on promising cancer cures which are being suppressed by the medical-industrial complex, see the deeply revealing reports from reliable major media sources available here.
Marijuana, already shown to reduce pain and nausea in cancer patients, may be promising as a cancer-fighting agent against some of the most aggressive forms of the disease. A growing body of early research shows a compound found in marijuana - one that does not produce the plant's psychotropic high - seems to have the ability to "turn off" the activity of a gene responsible for metastasis in breast and other types of cancers. Two scientists at San Francisco's California Pacific Medical Center Research Institute first released data five years ago that showed how this compound - called cannabidiol - reduced the aggressiveness of human breast cancer cells in the lab. "The preclinical trial data is very strong, and there's no toxicity. There's really a lot of research to move ahead with and to get people excited," said Sean McAllister, who along with scientist Pierre Desprez, has been studying the active molecules in marijuana - called cannabinoids - as potent inhibitors of metastatic disease for the past decade. Martin Lee, director of Project CBD, [a] group that works to raise awareness of the scientific promise of the compound, described the cannabidiol research as potent both as a medicine and a myth buster. "It debunks the idea that medicinal marijuana is really about people wanting to get stoned," said Lee, author of Smoke Signals, a book published last month about the medical and social history of marijuana. "Why do they want it when it doesn't even get them high?"
Note: For an educational, 45-minute documentary on this topic titled "What if Cannabis Cured Cancer?," click here. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply inspiring reports from reliable sources, click here.
Mounting evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Peer-reviewed studies in several countries ... show that THC and other marijuana-derived compounds, known as “cannabinoids,” are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. THC treatment was associated with significantly reduced tumor cell proliferation in every test subject. Harvard University scientists reported that THC slows tumor growth in common lung cancer and “significantly reduces the ability of the cancer to spread.” What’s more ... THC selectively targets and destroys tumor cells while leaving healthy cells unscathed. Conventional chemotherapy drugs, by contrast, are highly toxic; they indiscriminately damage the brain and body. There is mounting evidence ... that cannabinoids “represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells.” Within the medical science community, the discovery that cannabinoids have anti-tumoral properties is increasingly recognized as a seminal advancement in cancer therapeutics.
Note: Yet treatment with cannabinoids continues to be largely illegal in the US. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply revealing reports from reliable major media sources on promising cancer-cure research, click here.
A single treatment to cure all cancers? Scientists may be one step closer. In a recent study, scientists reported that they successfully tested an antibody treatment that shrank human breast, ovary, colon, bladder, brain, liver and prostate tumors transplanted into mice. The antibody blocks a protein called CD47, which normally sits on the cell surface and issues a “don’t eat me” signal that prevents the body’s immune system from attacking it. About a decade ago, scientists at Stanford University School of Medicine, led by professor of pathology Irving Weissman, discovered that using an antibody to block CD47 cured some cases of leukemia and lymphoma in mice by allowing macrophages to seek and destroy the cancerous cells. In the new study, Weissman’s Stanford team showed that the CD47-blocking antibodies may also work against a number of other cancers. The researchers found that CD47 existed on nearly every cell, which suggests that the protein may be common to all cancers. Cancer cells expressed about three times more CD47 than healthy cells. “If the tumor was highly aggressive, the antibody also blocked metastasis. It’s becoming very clear that, in order for a cancer to survive in the body, it has to find some way to evade the cells of the innate immune system,” said Weissman in a statement. The antibody treatment didn’t work in all cases. Some mice injected with breast cancer cells from a human patient showed no changes after treatment. Yet in five mice with breast cancer, the antibody treatment cured them, with no signs of recurrence four months after treatment.
Note: With millions around the world dying of cancer every year, why aren't the most promising treatments being fast tracked? Why did it take 10 years form Weissman to reach this stage? Why isn't the very promising treatment of DCA, which is both cheap and incredibly promising, being given many millions to move rapidly forward? To read major media articles describing other potential cures not being adequately funded, click here. To understand why some treatments are suppressed, click here.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.